The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments. As of Jan. 1, 2024, Sanofi cut the ...

Eli Lilly says it will cut the list price of its nonbranded insulin to $25 a vial as of May 1, making it the lowest list-priced mealtime insulin available. Its current list price is $82.41 for a vial.

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts ...

The top 3 insulin makers recently announced price cuts. Here’s what to know. Eli Lilly, Novo Nordisk and Sanofi all announced plans to cap prices on the diabetes treatment after pressure from ...

Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month.

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

They are no longer facing the highest insulin price, but their costs are still 10 times what they were just a few months ago, when they spent about $10 on three months’ worth of insulin.

In a study of insulin prices across 47 countries, costs ranged up to an entire month’s worth of wages. This means that in some places a person must spend their entire income on life-sustaining ...

The insulin price cap, part of a larger package of proposals to cut prescription drug and other health-care costs, was intended to limit out-of-pocket monthly insulin costs to $35 for most ...

Eli Lilly says it will cut the list price of its nonbranded insulin to $25 a vial as of May 1, making it the lowest list-priced mealtime insulin available. Its current list price is $82.41 for a vial.